Both KRAS and BRAF mutations will increase the proliferation rate in the cell, comparable to mutations in APC. The TGFb pathway has been shown to be abrogated later in the development, transforming an intermediate adenoma to a late adenoma. Here, BRAF is linked to adenoma.